What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Type 2 diabetes
Anthony H. Barnett mainly investigates Internal medicine, Type 2 diabetes, Diabetes mellitus, Endocrinology and Insulin. His studies deal with areas such as Gastroenterology, Placebo and Surgery as well as Internal medicine. His biological study spans a wide range of topics, including Metformin, Clinical endpoint, Randomized controlled trial, Disease and Type 2 Diabetes Mellitus.
His studies in Diabetes mellitus integrate themes in fields like Blood pressure, Pediatrics and Pharmacology. Anthony H. Barnett has researched Insulin in several fields, including Observational study and Type 1 diabetes. In his study, Genetics is strongly linked to Parenteral transmission, which falls under the umbrella field of Type 1 diabetes.
His most cited work include:
- Congenital leptin deficiency is associated with severe early-onset obesity in humans (2438 citations)
- Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. (744 citations)
- Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. (744 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Type 2 diabetes, Diabetes mellitus, Endocrinology and Insulin. His Internal medicine research incorporates themes from Gastroenterology, Exenatide, Placebo and Incretin. His Type 2 diabetes research includes elements of Metformin, Surgery, Intensive care medicine, Pharmacology and Type 2 Diabetes Mellitus.
His research integrates issues of Vildagliptin and Dipeptidyl peptidase-4 in his study of Pharmacology. His Diabetes mellitus research incorporates elements of Odds ratio, Obesity, Disease and Pediatrics. As part of his studies on Endocrinology, Anthony H. Barnett often connects relevant areas like Bioinformatics.
He most often published in these fields:
- Internal medicine (61.82%)
- Type 2 diabetes (57.14%)
- Diabetes mellitus (51.72%)
What were the highlights of his more recent work (between 2012-2020)?
- Type 2 diabetes (57.14%)
- Internal medicine (61.82%)
- Diabetes mellitus (51.72%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Type 2 diabetes, Internal medicine, Diabetes mellitus, Endocrinology and Insulin. The concepts of his Type 2 diabetes study are interwoven with issues in Obesity, Surgery, Intensive care medicine, Disease and Type 2 Diabetes Mellitus. Anthony H. Barnett has included themes like Placebo and Linagliptin in his Internal medicine study.
His Diabetes mellitus research focuses on Family history and how it connects with Young adult, Sedentary lifestyle and Pediatrics. As part of his studies on Endocrinology, he often connects relevant subjects like Bioinformatics. His Insulin study integrates concerns from other disciplines, such as Agonist and Empagliflozin.
Between 2012 and 2020, his most popular works were:
- Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. (744 citations)
- Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. (744 citations)
- Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial (352 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Gene
Anthony H. Barnett mostly deals with Type 2 diabetes, Diabetes mellitus, Internal medicine, Endocrinology and Type 2 Diabetes Mellitus. His work carried out in the field of Type 2 diabetes brings together such families of science as Odds ratio, Clinical endpoint, Insulin and Bioinformatics. The study incorporates disciplines such as Obstructive sleep apnea, Disease, Weight loss and Pharmacology in addition to Diabetes mellitus.
His research in Pharmacology intersects with topics in Metabolic control analysis, Pharmacotherapy and Dipeptidyl peptidase-4. His Internal medicine study combines topics in areas such as Placebo, Surgery and Linagliptin. His studies in Renal glucose reabsorption and Glycemic are all subfields of Endocrinology research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
